Oral Deforolimus With Trastuzumab for Patients With HER2-positive Trastuzumab-Refractory Metastatic Breast Cancer (8669-009)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
This clinical trial will study the use of ridaforolimus in metastatic breast cancer subjects whose tumors have shown a resistance to trastuzumab (herceptin). The goal of this study is to find out if subjects treated with ridaforolimus in combination with trastuzumab have a positive response to the treatment, and if treatment with ridaforolimus in combination with trastuzumab prolongs survival.
Epistemonikos ID: 5a2d9cf99ffc79ca87e4e686cfc4547e61ed751c
First added on: May 05, 2024